RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA vaccine aims to fight RSV in adults
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage study tests a new mRNA vaccine called IN006 for respiratory syncytial virus (RSV) in healthy adults aged 18 to 79. The vaccine is given as one shot, with some older adults getting a booster about a year later. The main goal is to check safety and how well the vac…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE1 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 13:58 UTC
-
New RSV vaccine trial aims to protect adults from severe lung infections
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine against respiratory syncytial virus (RSV) in adults. It involves 470 participants aged 18 and older (phase I) and 60 and older (phase II). The goal is to see if the vaccine is safe and triggers a strong immune response.
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 13:56 UTC
-
New study aims to shield infants from deadly RSV
Prevention Not yet recruitingThis study looks at how well two prevention methods work against severe RSV in babies under 6 months old in Bogotá. One method is a vaccine given to mothers during pregnancy, and the other is an antibody shot given to newborns whose mothers didn't get the vaccine. Researchers wil…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Sponsor: Bogotá District Health Secretariat • Aim: Prevention
Last updated May 06, 2026 16:02 UTC
-
Scottish health records to reveal RSV vaccine's real-world impact on newborns
Knowledge-focused Not yet recruitingThis study will use Scotland's national health records to see if babies born to mothers who received the RSV vaccine (ABRYSVO) are less likely to be hospitalized with severe RSV. Researchers will compare vaccinated and unvaccinated groups, following infants up to 12 months old. N…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC